The PANSS (Positive and Negative Syndrome Scale) explained

If you have ever read a schizophrenia drug trial, you have probably seen the abbreviation PANSS — the Positive and Negative Syndrome Scale. It is the most widely used research instrument for measuring the severity of schizophrenia symptoms. The FDA accepts PANSS-based outcomes as evidence in approval decisions, and most of what we know about how well antipsychotics work comes from changes in PANSS scores. This guide explains what the PANSS measures, how it is scored, and how to interpret the numbers when they show up in a paper or a clinic note.

Where it came from

The PANSS was developed in 1987 by Stanley Kay, Lewis Opler, and Abraham Fiszbein, based on earlier work including the Brief Psychiatric Rating Scale (BPRS) and the Psychopathology Rating Scale. Their goal was to create a single instrument that captured both positive symptoms (which earlier scales handled well) and negative symptoms (which earlier scales largely missed). The original validation paper has been cited tens of thousands of times and the scale has been translated into more than thirty languages.

How it is administered

A trained clinician interviews the patient for roughly 30 to 50 minutes, often using the Structured Clinical Interview for the PANSS (SCI-PANSS) to ensure consistency. The clinician then scores each of 30 items on a scale from 1 (absent) to 7 (extreme), based on observations during the interview, the patient's report, and ideally information from family or caregivers.

The three subscales

Positive scale (7 items)

• P1 Delusions
• P2 Conceptual disorganisation
• P3 Hallucinatory behaviour
• P4 Excitement
• P5 Grandiosity
• P6 Suspiciousness/persecution
• P7 Hostility

Negative scale (7 items)

• N1 Blunted affect
• N2 Emotional withdrawal
• N3 Poor rapport
• N4 Passive/apathetic social withdrawal
• N5 Difficulty in abstract thinking
• N6 Lack of spontaneity and flow of conversation
• N7 Stereotyped thinking

General psychopathology scale (16 items)

This third subscale covers symptoms that occur in many psychiatric conditions but are common in schizophrenia, including somatic concern, anxiety, guilt feelings, tension, mannerisms and posturing, depression, motor retardation, uncooperativeness, unusual thought content, disorientation, poor attention, lack of judgement and insight, disturbance of volition, poor impulse control, preoccupation, and active social avoidance.

How scores are interpreted

Each item is scored 1 to 7. Sum the scores within each subscale to get:

• Positive subscale: 7 to 49
• Negative subscale: 7 to 49
• General psychopathology subscale: 16 to 112
• Total PANSS score: 30 to 210

A widely cited paper by Leucht and colleagues in Schizophrenia Research mapped PANSS total scores to the Clinical Global Impression scale and provided rough anchors:

• ≈ 58: mildly ill
• ≈ 75: moderately ill
• ≈ 95: markedly ill
• ≈ 116: severely ill

These are population averages, not personal verdicts. Two people with the same total score can have very different symptom profiles depending on which subscale dominates.

Reading PANSS results in research papers

Drug trials usually report two things: the absolute change in PANSS total score from baseline (a "−15.4 point reduction at week 6") and the percentage of patients achieving "response," typically defined as a 30% or 50% reduction from baseline. Differences between an active drug and placebo of around 6 to 10 points on the total PANSS are clinically meaningful in acute schizophrenia trials.

Watch for several things when reading these papers:

• Baseline severity: Trials that include only severely ill patients (PANSS ≥ 90) tend to show larger absolute changes than trials that allow milder patients.
• Subscale changes: A drug might dramatically improve positive symptoms while leaving negative symptoms unchanged. Total scores can hide this.
• Drop-out: PANSS analyses depend on whether last observations are carried forward or only completers are analysed.
• Effect sizes: Reported as Cohen's d or as standardised mean differences. For acute schizophrenia, effect sizes of 0.4 to 0.5 are typical for active medications versus placebo.

Strengths and limits of the PANSS

Strengths

• Comprehensive — captures positive, negative, and general symptoms
• Excellent inter-rater reliability when clinicians are trained
• Forty years of accumulated comparative data
• Translated and validated in dozens of languages

Limits

• Long — 30 to 50 minutes per administration
• Requires trained, certified raters for research use
• Some items overlap (for example, several items capture aspects of social withdrawal)
• Negative symptom items have been criticised for capturing depression and apathy in ways that blur the boundaries
• Less sensitive to cognitive symptoms, which are often measured separately

The PANSS in routine clinical care

In day-to-day clinical practice the PANSS is rarely used. It is too long for routine appointments and most clinicians use briefer scales or open clinical judgement. Where you are most likely to encounter your own PANSS score is if you are participating in a clinical trial or being seen in a specialised research clinic. If you do see a PANSS score in your records, the breakdown by subscale is more informative than the total — it tells you which symptom domain is currently most prominent.

How the PANSS relates to other scales

The PANSS overlaps significantly with the older BPRS, which has only 18 items but covers many of the same domains. The Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS) are alternatives that focus more deeply on each domain. Newer instruments like the Brief Negative Symptom Scale (BNSS) and the Clinical Assessment Interview for Negative Symptoms (CAINS) try to address weaknesses in how the PANSS handles negative symptoms.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.